Click to view 3D structure | D(2) dopamine receptor | P14416 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.206
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.7665
- Supporting Reference Compounds
- 1103
- E-value
- 5967.14
|
Click to view 3D structure | D(4) dopamine receptor | P21917 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.206
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.6163
- Supporting Reference Compounds
- 524
- E-value
- 4797.69
|
Click to view 3D structure | D(3) dopamine receptor | P35462 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.204
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.7491
- Supporting Reference Compounds
- 861
- E-value
- 5831.92
|
Click to view 3D structure | 5-hydroxytryptamine receptor 2A | P28223 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.202
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.8032
- Supporting Reference Compounds
- 955
- E-value
- 6252.93
|
Click to view 3D structure | 5-hydroxytryptamine receptor 2C | P28335 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.201
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.7996
- Supporting Reference Compounds
- 823
- E-value
- 6224.59
|
Click to view 3D structure | Carbonic anhydrase 2 | P00918 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.196
- Applicability Domain
- 0.222 Low confidence
- Statistical Significance
- 0.6264
- Supporting Reference Compounds
- 472
- E-value
- 4876.24
|
Click to view 3D structure | Metabotropic glutamate receptor 3 | P31422 | Rattus norvegicus | Predicted (SEA) | - Prediction Confidence Score
- 0.194
- Applicability Domain
- 0.204 Low confidence
- Statistical Significance
- 0.1195
- Supporting Reference Compounds
- 39
- E-value
- 930.61
|
Click to view 3D structure | 5-hydroxytryptamine receptor 2A | P14842 | Rattus norvegicus | Predicted (SEA) | - Prediction Confidence Score
- 0.193
- Applicability Domain
- 0.204 Low confidence
- Statistical Significance
- 0.6528
- Supporting Reference Compounds
- 380
- E-value
- 5082.23
|
Click to view 3D structure | 5-hydroxytryptamine receptor 6 | P50406 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.193
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.77
- Supporting Reference Compounds
- 536
- E-value
- 5994.78
|
Click to view 3D structure | Carbonic anhydrase 12 | O43570 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.192
- Applicability Domain
- 0.222 Low confidence
- Statistical Significance
- 0.5756
- Supporting Reference Compounds
- 332
- E-value
- 4480.77
|
Click to view 3D structure | D(2) dopamine receptor | P61169 | Rat | Predicted (SEA) | - Prediction Confidence Score
- 0.192
- Applicability Domain
- 0.2 Low confidence
- Statistical Significance
- 0.6948
- Supporting Reference Compounds
- 528
- E-value
- 5409.2
|
Click to view 3D structure | Histamine H1 receptor | P35367 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.192
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.8101
- Supporting Reference Compounds
- 507
- E-value
- 6306.88
|
Click to view 3D structure | 5-hydroxytryptamine receptor 1A | P08908 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.191
- Applicability Domain
- 0.2 Low confidence
- Statistical Significance
- 0.8743
- Supporting Reference Compounds
- 953
- E-value
- 6806.44
|
Click to view 3D structure | Muscarinic acetylcholine receptor M1 | P11229 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.191
- Applicability Domain
- 0.229 Low confidence
- Statistical Significance
- 0.7921
- Supporting Reference Compounds
- 385
- E-value
- 6166.59
|
Click to view 3D structure | Alpha-2A adrenergic receptor | P08913 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.19
- Applicability Domain
- 0.2 Low confidence
- Statistical Significance
- 0.8199
- Supporting Reference Compounds
- 487
- E-value
- 6382.94
|
Click to view 3D structure | Alpha-2C adrenergic receptor | P18825 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.19
- Applicability Domain
- 0.2 Low confidence
- Statistical Significance
- 0.7378
- Supporting Reference Compounds
- 386
- E-value
- 5743.87
|
Click to view 3D structure | Muscarinic acetylcholine receptor M2 | P10980 | Rattus norvegicus | Predicted (SEA) | - Prediction Confidence Score
- 0.189
- Applicability Domain
- 0.229 Low confidence
- Statistical Significance
- 0.2967
- Supporting Reference Compounds
- 98
- E-value
- 2309.48
|
Click to view 3D structure | 5-hydroxytryptamine receptor 2B | P41595 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.189
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.8948
- Supporting Reference Compounds
- 686
- E-value
- 6966.18
|
Click to view 3D structure | Alpha-2B adrenergic receptor | P18089 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.189
- Applicability Domain
- 0.2 Low confidence
- Statistical Significance
- 0.7419
- Supporting Reference Compounds
- 340
- E-value
- 5775.87
|
Click to view 3D structure | Carbonic anhydrase 9 | Q16790 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.188
- Applicability Domain
- 0.222 Low confidence
- Statistical Significance
- 0.6522
- Supporting Reference Compounds
- 372
- E-value
- 5077.48
|
Click to view 3D structure | Metabotropic glutamate receptor 8 | O00222 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.187
- Applicability Domain
- 0.204 Low confidence
- Statistical Significance
- 0.171
- Supporting Reference Compounds
- 48
- E-value
- 1331.38
|
Click to view 3D structure | Sigma non-opioid intracellular receptor 1 | Q99720 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.187
- Applicability Domain
- 0.196 Low confidence
- Statistical Significance
- 0.8611
- Supporting Reference Compounds
- 562
- E-value
- 6703.83
|
Click to view 3D structure | Metabotropic glutamate receptor 1 | Q13255 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.187
- Applicability Domain
- 0.204 Low confidence
- Statistical Significance
- 0.3454
- Supporting Reference Compounds
- 68
- E-value
- 2688.6
|
Click to view 3D structure | Carbonic anhydrase 4 | P22748 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.185
- Applicability Domain
- 0.194 Low confidence
- Statistical Significance
- 0.5306
- Supporting Reference Compounds
- 193
- E-value
- 4130.6
|
Click to view 3D structure | Cytochrome P450 2C9 | P11712 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.184
- Applicability Domain
- 0.2 Low confidence
- Statistical Significance
- 0.9738
- Supporting Reference Compounds
- 1245
- E-value
- 7581.19
|
Click to view 3D structure | Actin, alpha skeletal muscle | P68133 | Humans | Known | Arsenic binds to actin. (A16) |
Click to view 3D structure | Actin, aortic smooth muscle | P62736 | Humans | Known | Arsenic binds to actin. (A16) |
Click to view 3D structure | Actin, cytoplasmic 1 | P60709 | Humans | Known | Arsenic binds to actin. (A16) |
Click to view 3D structure | Actin, cytoplasmic 2 | P63261 | Humans | Known | Arsenic binds to actin. (A16) |
Click to view 3D structure | Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial | P10515 | Humans | Known | Arsenic disrupts ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1) |
Click to view 3D structure | Estrogen receptor | P03372 | Humans | Known | Arsenic binds to the estrogen receptor. (A17) |
Click to view 3D structure | Glucocorticoid receptor | P04150 | Humans | Known | Arsenic binds to the glucocorticoid receptor. (A17) |
Click to view 3D structure | Glutathione reductase, mitochondrial | P00390 | Humans | Known | Arsenic binds glutathione reductase, which results in the inhibition of essential biochemical reactions, alteration of cellular redox status, and eventual cytotoxicity. (L2) |
Click to view 3D structure | Hemoglobin subunit alpha | P69905 | Humans | Known | Arsenic binds to hemoglobin. (A15) |
Click to view 3D structure | Hemoglobin subunit beta | P68871 | Humans | Known | Arsenic binds to hemoglobin. (A15) |
Click to view 3D structure | Kelch-like ECH-associated protein 1 | Q14145 | Humans | Known | Arsenic binds to kelch-like ECH-associated protein 1. (A17) |
Click to view 3D structure | Poly [ADP-ribose] polymerase 1 | P09874 | Humans | Known | Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17) |
Click to view 3D structure | Tubulin-like protein alpha-4B | Q9H853 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | P08559 | Humans | Known | Arsenic disrupts ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1) |
Click to view 3D structure | Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial | P29803 | Humans | Known | Arsenic disrupts ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1) |
Click to view 3D structure | Pyruvate dehydrogenase E1 component subunit beta, mitochondrial | P11177 | Humans | Known | Arsenic disrupts ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1) |
Click to view 3D structure | Thioredoxin reductase 1, cytoplasmic | Q16881 | Humans | Known | Arsenic binds thioredoxin reductase, which results in the inhibition of essential biochemical reactions, alteration of cellular redox status, and eventual cytotoxicity. (L2) |
Click to view 3D structure | Thioredoxin reductase 2, mitochondrial | Q9NNW7 | Humans | Known | Arsenic binds thioredoxin reductase, which results in the inhibition of essential biochemical reactions, alteration of cellular redox status, and eventual cytotoxicity. (L2) |
Click to view 3D structure | Tubulin alpha-1A chain | Q71U36 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin alpha-1B chain | P68363 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin alpha-1C chain | Q9BQE3 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin alpha-3E chain | Q6PEY2 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin alpha-4A chain | P68366 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin alpha-8 chain | Q9NY65 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta chain | P07437 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta-1 chain | Q9H4B7 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta-2A chain | Q13885 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta-2B chain | Q9BVA1 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta-3 chain | Q13509 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta-4A chain | P04350 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta-4B chain | P68371 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |
Click to view 3D structure | Tubulin beta-6 chain | Q9BUF5 | Humans | Known | Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17) |